Intravitreal Dexamethasone in Diabetic Macular Oedema: A Way of Enhancing the Response to Anti-VEGF in Non- or Poor Responders?

Volume: 245, Issue: 4, Pages: 350 - 357
Published: Sep 29, 2021
Abstract
<b><i>Background and Purpose:</i></b> The aim of this study was to describe the outcomes of a switch back to anti-vascular endothelial growth factor (VEGF) in diabetic macular oedema (DME) eyes treated temporarily with a dexamethasone implant (DEXi), after an initial poor response to anti-VEGF. <b><i>Methods:</i></b> The study involved a case series. <b><i>Results:</i></b>...
Paper Details
Title
Intravitreal Dexamethasone in Diabetic Macular Oedema: A Way of Enhancing the Response to Anti-VEGF in Non- or Poor Responders?
Published Date
Sep 29, 2021
Volume
245
Issue
4
Pages
350 - 357
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.